↓ Skip to main content

Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib

Overview of attention for article published in Breast Cancer Research, November 2017
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
63 Mendeley